Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2004

View Archived Issues

AOP and Lantibio enter licensing agreement for Moli-1901

Allergan and Kyorin sign Japanese agreement for Alphagan franchise

Concurrent to acquire Allergan retinoid portfolio

LeuTech to be renamed NeutroSpec

Praecis updates Plenaxis progress and highlights clinical program developments

PG-490-88 prolongs survival in renal allograft models

Farnesyltransferase inhibitor delays development of acute rejection

JAK-3 inhibition prevents obliterative bronchiolitis after tracheal transplantation

Preclinical milestone reached in Neurogen/Merck & Co pain alliance

Metvix launch under way in Australia

Six months additional exclusivity for Agrylin

European MAA submitted for liquid Aricept

New ATS guidelines recommend use of tiotropium for COPD

Biotronik enters distribution deal for Conor Medsystems' Costar stent

Xanodyne launches hycet

Yamanouchi and Pfizer restructure Japan partnership

Termination of Genasense Expanded Access Program

Myriad Genetics achieves significant progress on many fronts during third quarter

BioMarin highlights first quarter developments

Clinical efficacy of an olmesartan medoxomil/hydrochlorothiazide combination in hypertension

PGN-0052 induces bronchodilatation in patients with mild to moderate asthma

EPI-12323 reduces the severity of late allergic reactions in asthmatics

Therapeutic benefits found with ambrisentan in PAH

UCB-35440-3 relieves bronchoconstriction in vivo

Preclinical results on activity of OPC-6535 in COPD

Nebulized doripenem effective in P. aeruginosa pneumonia model

Merck KGaA presents bispecific anti-ErbB antibodies for cancer therapy

Scios researchers describe new p38alpha inhibitors

Novel 5-HT6 receptor ligands identified by Roche scientists

Elan patent covers new bradykinin antagonists for pain and other uses

New cannabinoid CB1 antagonists in early development at Pfizer

New FAAH inhibitors with potential utility as analgesic agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...